Induction of Apoptosis and Sensitization of Head and Neck Squamous Carcinoma Cells to Cisplatin by Targeting Survivin Gene Expression

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|12|6|444-453

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.12, Iss.6, 2012-12, pp. : 444-453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cisplatin + capecitabine active in head, neck squamous cell carcinoma

By  

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma

By Sundvall Maria   Karrila Anna   Nordberg Janne   Grénman Reidar   Elenius Klaus  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 185-201

Informa Healthcare

Access to resources Recommend Favorite

Oxaliplatin-mediated Inhibition of Survivin Increases Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines to Paclitaxel

By  

Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. : 660-669

Bentham Science Publishers

Access to resources Recommend Favorite

Progress and Pitfalls in the Identification of Cancer Stem Cell-Targeting Therapies in Head and Neck Squamous Cell Carcinoma

By  

Current Medicinal Chemistry, Vol. 19, Iss. 35, 2012-12 ,pp. : 6056-6064

Bentham Science Publishers

Access to resources Recommend Favorite

Dual EGFR and COX-2 Inhibition as a Novel Approach to Targeting Head and Neck Squamous Cell Carcinoma

By  

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 931-937

Bentham Science Publishers

Access to resources Recommend Favorite